- Home
- Publications
- Publication Search
- Publication Details
Title
Metronomic Chemotherapy
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 9, Pages 2236
Publisher
MDPI AG
Online
2021-05-06
DOI
10.3390/cancers13092236
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC). Analysis of survival and value of ctDNA for patient selection
- (2021) Mariano Provencio et al. LUNG CANCER
- Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial
- (2021) A. Camerini et al. ESMO Open
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phase III trial of metronomic capecitabine maintenance after standard treatment in operable triple-negative breast cancer (SYSUCC-001).
- (2020) XI Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical recommendations on lung cancer management during the COVID ‐19 pandemic
- (2020) Yan Xu et al. Thoracic Cancer
- Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers
- (2020) Luana Schito et al. EMBO Molecular Medicine
- Effect of low dose metronomic therapy on MCF-7 tumor cells growth and angiogenesis. Role of muscarinic acetylcholine receptors
- (2020) A.R. Salem et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage
- (2020) Xiuwen Guan et al. Frontiers in Oncology
- Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer
- (2020) Kabir A. Khan et al. npj Breast Cancer
- 1983P Metronomic combination of 5-fluorouracil plus vinorelbine limits endothelial and triple-negative breast cancer cells proliferation and migration and abolishes clonogenic survival
- (2020) M.G. Cerrito et al. ANNALS OF ONCOLOGY
- A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancer
- (2020) M.R. Hall et al. GYNECOLOGIC ONCOLOGY
- Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
- (2020) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial
- (2020) Vijay Patil et al. Lancet Global Health
- De-escalating cancer treatments during COVID 19 pandemic: Is metronomic chemotherapy a reasonable option?
- (2020) Palma Fedele et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Evaluation of metronomic chemotherapy response using diffusion and dynamic contrast-enhanced MRI
- (2020) Mehran Baboli et al. PLoS One
- Efficacy and Safety of Pembrolizumab in Combination With Bevacizumab and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Ovarian Cancer
- (2020) Emese Zsiros et al. JAMA Oncology
- Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience
- (2019) Cem Simsek et al. Journal of Oncology
- SFCE METRO‐01 four‐drug metronomic regimen phase II trial for pediatric extracranial tumor
- (2019) Marie‐Amélie Heng‐Maillard et al. PEDIATRIC BLOOD & CANCER
- Differential Involvement of Autophagy and Apoptosis in Response to Chemoendocrine and Endocrine Therapy in Breast Cancer: JBCRG-07TR
- (2019) Takayuki Ueno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial
- (2019) Chiara Cremolini et al. EUROPEAN JOURNAL OF CANCER
- Next Viable Routes to Targeting Pancreatic Cancer Stemness: Learning from Clinical Setbacks
- (2019) Kelvin K. Tsai et al. Journal of Clinical Medicine
- Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trial
- (2019) Marco Platania et al. LUNG CANCER
- Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer
- (2019) Vijay M. Patil et al. JOURNAL OF CLINICAL ONCOLOGY
- An individual patient-data meta-analysis of metronomic oral vinorelbine in metastatic non-small cell lung cancer
- (2019) Jean-Louis Pujol et al. PLoS One
- Combination of metronomic administration and target delivery strategies to improve the anti-angiogenic and anti-tumor effects of triptolide
- (2019) Xin-jun Cai et al. Drug Delivery and Translational Research
- Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study
- (2019) M.E. Cazzaniga et al. BREAST
- A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors
- (2019) Muna Qayed et al. PEDIATRIC BLOOD & CANCER
- Metronomic vinorelbine is directly active on Non Small Cell Lung Cancer cells and sensitizes the EGFRL858R/T790M cells to reversible EGFR tyrosine kinase inhibitors
- (2018) Paola Orlandi et al. BIOCHEMICAL PHARMACOLOGY
- Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00
- (2018) Elisabetta Munzone et al. BREAST CANCER RESEARCH AND TREATMENT
- Explorative Analysis of Low-Dose Metronomic Chemotherapy with Cyclophosphamide and Methotrexate in a Cohort of Metastatic Breast Cancer Patients
- (2018) Slavomir Krajnak et al. Breast Care
- Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II Trial
- (2018) Emilia Montagna et al. Breast Care
- Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma
- (2018) Stefania Orecchioni et al. BRITISH JOURNAL OF CANCER
- Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy
- (2018) Junjie Wu et al. CANCER LETTERS
- Does metronomic chemotherapy induce tumor angiogenic dormancy? A review of available preclinical and clinical data
- (2018) Gianfranco Natale et al. CANCER LETTERS
- Metronomic combination of vinorelbine and 5Fluorouracil inhibit triple-negative breast cancer cells results from the proof-of-concept VICTOR-0 study
- (2018) Maria Grazia Cerrito et al. Oncotarget
- Metronomics: Intrinsic Anakoinosis Modulator?
- (2018) André Nicolas et al. Frontiers in Pharmacology
- Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas
- (2018) Maud Toulmonde et al. JAMA Oncology
- Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE Project
- (2018) Marina E. Cazzaniga et al. ADVANCES IN THERAPY
- Metronomic oral vinorelbine for the treatment of advanced non-small cell lung cancer: a multicenter international retrospective analysis
- (2018) A. Camerini et al. Clinical & Translational Oncology
- Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant, recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trial
- (2017) C. Dinkic et al. GYNECOLOGIC ONCOLOGY
- Myeloid-derived suppressor cells—a new therapeutic target to overcome resistance to cancer immunotherapy
- (2017) Jason A. Chesney et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas
- (2017) Katherine B. Peters et al. JOURNAL OF NEURO-ONCOLOGY
- Metronomic therapy has low toxicity and is as effective as current standard treatment for recurrent high-risk neuroblastoma
- (2017) Frank Berthold et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev)
- (2017) Pierpaolo Pastina et al. Oncotarget
- Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors
- (2017) Raja Pramanik et al. JAMA Oncology
- The efficacy and toxicity profile of metronomic chemotherapy for metastatic breast cancer: A meta-analysis
- (2017) Yangyang Liu et al. PLoS One
- SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial
- (2016) Christoph Rochlitz et al. BMC CANCER
- Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study
- (2016) M. E. Cazzaniga et al. BREAST CANCER RESEARCH AND TREATMENT
- Results of a randomized, prospective clinical trial evaluating metronomic chemotherapy in nonmetastatic patients with high-grade, operable osteosarcomas of the extremities: A report from the Latin American Group of Osteosarcoma Treatment
- (2016) Andreza A. Senerchia et al. CANCER
- Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy
- (2016) Y. Shaked et al. CANCER RESEARCH
- Current achievements and future perspectives of metronomic chemotherapy
- (2016) Adriana Romiti et al. INVESTIGATIONAL NEW DRUGS
- Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor–Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00
- (2016) Marco Colleoni et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma
- (2016) D. Jay McCracken et al. JOURNAL OF NEURO-ONCOLOGY
- Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors
- (2016) Kieuhoa T. Vo et al. Oncotarget
- Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different Schedules
- (2016) Natalia Sutiman et al. PLoS One
- A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first-line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial
- (2015) H. Hagman et al. ANNALS OF ONCOLOGY
- The treatment patterns, efficacy, and safety of nab®-paclitaxel for the treatment of metastatic breast cancer in the United States: results from health insurance claims analysis
- (2015) Caihua Liang et al. BMC CANCER
- Cisplatin in combination with metronomic vinorelbine as front-line treatment in advanced non-small cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
- (2015) P. Katsaounis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group
- (2015) Lieke H J Simkens et al. LANCET
- Metronomic vinorelbine (oral) in combination with sorafenib in advanced non-small cell lung cancer
- (2015) Eng Huat Tan et al. LUNG CANCER
- On and off Metronomic Oral Vinorelbine in Elderly Women with Advanced Breast Cancer
- (2015) Francesca De Iuliis et al. TUMORI
- Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence
- (2015) Sabine Taschner-Mandl et al. Oncotarget
- On and off Metronomic Oral Vinorelbine in Elderly Women with Advanced Breast Cancer
- (2015) Francesca De Iuliis et al. TUMORI JOURNAL
- Optimal duration of systemic treatment in metastatic colorectal cancer
- (2014) Lieke H.J. Simkens et al. CURRENT OPINION IN ONCOLOGY
- Bevacizumab in Combination with Metronomic Chemotherapy in Patients with Anthracycline- and Taxane-Refractory Breast Cancer
- (2014) J.A. García-Sáenz et al. JOURNAL OF CHEMOTHERAPY
- Lenalidomide and metronomic melphalan for CMML and higher risk MDS: A phase 2 clinical study with biomarkers of angiogenesis
- (2014) Rena Buckstein et al. LEUKEMIA RESEARCH
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic efficacy of metronomic chemotherapy with cyclophosphamide and doxorubicin on murine mammary adenocarcinomas
- (2013) L. E. Mainetti et al. ANNALS OF ONCOLOGY
- A phase I study of irinotecan in combination with metronomic temozolomide in patients with recurrent glioblastoma
- (2013) Gaspar Reynés et al. ANTI-CANCER DRUGS
- Phase II Trial of Fulvestrant With Metronomic Capecitabine for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
- (2013) Lee S. Schwartzberg et al. Clinical Breast Cancer
- Low-dose metronomic chemotherapy: A systematic literature analysis
- (2013) K. Lien et al. EUROPEAN JOURNAL OF CANCER
- Preliminary evaluation of children treated with metronomic chemotherapy and valproic acid in a low-income country: Metro-Mali-02
- (2013) F Traore et al. INDIAN JOURNAL OF CANCER
- Efficacy and safety of metronomic administration of paclitaxel for advanced recurrent non-small-cell lung cancer
- (2013) K Prabhash et al. INDIAN JOURNAL OF CANCER
- Metronomic chemotherapy following the maximum tolerated dose is an effective anti-tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cells
- (2013) Marta Vives et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers
- (2012) Giacomo Allegrini et al. ANGIOGENESIS
- Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomics
- (2012) Erica L. Mayer et al. BREAST CANCER RESEARCH AND TREATMENT
- Oral Metronomic Cyclophosphamide and Methotrexate Plus Fulvestrant in Advanced Breast Cancer Patients: A Mono-Institutional Case-Cohort Report
- (2012) Gaetano Aurilio et al. Breast Journal
- Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer
- (2012) Masataka Yoshimoto et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Metronomic Chemotherapy Combined With Bevacizumab and Erlotinib in Patients With Metastatic HER2-Negative Breast Cancer: Clinical and Biological Activity
- (2012) Emilia Montagna et al. Clinical Breast Cancer
- The efficacy of temozolomide for recurrent glioblastoma multiforme
- (2012) Chao Chen et al. EUROPEAN JOURNAL OF NEUROLOGY
- Exploratory predictive and prognostic factors in advanced breast cancer treated with metronomic chemotherapy
- (2011) Manuela Miscoria et al. ANTI-CANCER DRUGS
- The PACOVAR-trial: A phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer
- (2011) Michael Eichbaum et al. BMC CANCER
- Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients
- (2011) Pierpaolo Correale et al. CANCER BIOLOGY & THERAPY
- An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study
- (2011) Zhonghua Wang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer
- (2011) P. Fedele et al. EUROPEAN JOURNAL OF CANCER
- Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer
- (2011) Martin R. Stockler et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimal treatment for recurrent/metastatic head and neck cancer
- (2010) J. B. Vermorken et al. ANNALS OF ONCOLOGY
- Metastatic cancer stem cells: A new target for anti-cancer therapy?
- (2010) Patrick C. Hermann et al. CELL CYCLE
- Study of Low-Dose Capecitabine Monotherapy for Metastatic Breast Cancer
- (2010) Tetsuya Taguchi et al. CHEMOTHERAPY
- Low-Dose Metronomic Oral Administration of Vinorelbine in the First-line Treatment of Elderly Patients With Metastatic Breast Cancer
- (2010) Raffaele Addeo et al. Clinical Breast Cancer
- A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma
- (2010) Julia R. Sharp et al. EUROPEAN JOURNAL OF CANCER
- Circulating thrombospondin 1 level as a surrogate marker in patients receiving cyclophosphamide-based metronomic chemotherapy
- (2010) Amélie Lansiaux et al. INVESTIGATIONAL NEW DRUGS
- A phase II study of metronomic oral topotecan for recurrent childhood brain tumors
- (2010) Jane E. Minturn et al. PEDIATRIC BLOOD & CANCER
- To widen the setting of cancer patients who could benefit from metronomic capecitabine
- (2009) Margherita Nannini et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Classification of Chemotherapeutic Agents Based on Their Differential In vitro Effects on Dendritic Cells
- (2009) H. Tanaka et al. CANCER RESEARCH
- Dual Therapeutic Efficacy of Vinblastine as a Unique Chemotherapeutic Agent Capable of Inducing Dendritic Cell Maturation
- (2009) H. Tanaka et al. CANCER RESEARCH
- Phase I/II Trial of Metronomic Chemotherapy With Daily Dalteparin and Cyclophosphamide, Twice-Weekly Methotrexate, and Daily Prednisone As Therapy for Metastatic Breast Cancer Using Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor Levels As Markers of Response
- (2009) Nan Soon Wong et al. JOURNAL OF CLINICAL ONCOLOGY
- Continuous Administration of Daily Low-Dose Temozolomide in Pretreated Patients with Advanced Non-Small Cell Lung Cancer: A Phase II Study
- (2009) Charalambos Kouroussis et al. ONCOLOGY
- A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients
- (2008) G Allegrini et al. BRITISH JOURNAL OF CANCER
- Metronomic Cyclophosphamide and Capecitabine Combined With Bevacizumab in Advanced Breast Cancer
- (2008) Silvia Dellapasqua et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started